Search
Rohan Hockings says there are 10 times as many drug targets inside a cell wall as on the surface. Photo: Attila Csaszar

No hard cell for Phylogica

Founded in 2005 as a spin-off from the Telethon Child Health Institute, Perth-based biotech Phylogica recently passed a milestone in efforts to commercialise its expansive library of disease-fighting genetic sequences, or genomes.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Phylogica (PYC)

Share Price

Closing price for the last 90 trading days
Source: Morningstar

BNiQ Disclaimer